Religion as a protective factor against drug use among Brazilian university students: a national survey

Imagem de Miniatura
Arquivos
art_ANDRADE_Religion_as_a_protective_factor_against_drug_use_2013.PDF (3.17 MB)
Citações na Scopus
82
Tipo de produção
article
Data de publicação
2013
Editora
ASSOC BRASILEIRA PSIQUIATRIA
DOI
Indexadores
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
GOMES, Fernanda Carolina
IZBICKI, Rafael
ALMEIDA, Alexander Moreira
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
REVISTA BRASILEIRA DE PSIQUIATRIA, v.35, n.1, p.29-37, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To investigate the relationship between religiosity and drug use among Brazilian university students. Methods: This manuscript is part of the ""First Nationwide Survey on the Use of Alcohol, Tobacco and Other Drugs among College Students in the 27 Brazilian State Capitals"". In this study, 12,595 university students were divided into two groups according to their attendance at religious services: frequent attenders (FR; 39.1%) and non-frequent attenders (NFR; 60.8%). Subsequently, we analyzed their responses to a structured, anonymous questionnaire on drug use and other behaviors. Individual multivariate logistic regression models tested the association between religiosity and drug use (alcohol, tobacco, marijuana and at least one illicit drug). Results: Drug use over the last 30 days was higher among NFR students even after controlling for demographic variables. NFR students were more likely to use alcohol OR = 2.52; 95% CI: 2.08-3.06, tobacco (2.83; 2.09-3.83), marijuana (2.09; 1.39-3.11) and at least one illicit drug (1.42; 1.12-1.79) compared to FR students. Conclusion: Religiosity was found to be a strongly protective factor against drug use among Brazilian university students. However, more studies are needed to identify the mechanisms by which religiosity exerts this protective influence.
Palavras-chave
Religion and Medicine, Street Drugs, Cross-Sectional Study, Students, Brazil
URI
https://observatorio.fm.usp.br/handle/OPI/2138
Referências
  1. Abdel-Khalek AM, 2011, PSYCHOL REP, V108, P54, DOI 10.2466/07.17.PR0.108.1.54-58
  2. Abdel-Khalek AM, 2010, QUAL LIFE RES, V19, P1133, DOI 10.1007/s11136-010-9676-7
  3. ABEP, 2008, CRIT CLASS EC BRAS
  4. Andrade AG, 2010, 1 NATIONWIDE SURVEY
  5. Blay SL, 2008, AM J GERIAT PSYCHIAT, V16, P934, DOI 10.1097/JGP.0b013e3181871392
  6. Borini P, 1994, J BRAS PSIQUIATR, V43, P93
  7. Chen CY, 2004, AM J EPIDEMIOL, V159, P1180, DOI 10.1093/aje/kwh151
  8. Cook CCH, 2004, ADDICTION, V99, P539, DOI 10.1111/j.1360-0443.2004.00715.x
  9. Cook CCH, 2006, ADDICTION, V101, P761
  10. Dalgalarrondo Paulo, 2004, Revista Brasileira de Psiquiatria, V26, P82, DOI 10.1590/S1516-44462004000200004
  11. Edlund MJ, 2010, SOC PSYCH PSYCH EPID, V45, P827, DOI 10.1007/s00127-009-0124-3
  12. ENGS RC, 1980, DRUG ALCOHOL DEPEN, V6, P231, DOI 10.1016/0376-8716(80)90328-2
  13. Geppert C, 2007, DRUG ALCOHOL REV, V26, P389, DOI 10.1080/09595230701373826
  14. Johnson TJ, 2008, J STUD ALCOHOL DRUGS, V69, P160
  15. Johnston LD, 2009, NIH PUBLICATION, V09-7403
  16. King MB, 2009, BMC HEALTH SERV RES, V13, P1
  17. Luna A, 1992, Med Law, V11, P3
  18. Moore EW, 2011, J RELIG HLTH
  19. Moreira-Almeida A, 2006, REV BRAS PSIQUIATR, V28, P242, DOI 10.1590/S1516-44462006005000006
  20. Moreira-Almeida A, 2010, REV PSIQUIATR CLIN, V37, P12, DOI 10.1590/S0101-60832010000100003
  21. Oliveira LG, 2010, LEVANTAMENTO NACL US, P181
  22. PARFREY PS, 1976, SCAND J SOC MED, V4, P135
  23. Parsai M, 2010, BRIT J SOC WORK, V40, P100, DOI 10.1093/bjsw/bcn100
  24. Piko BF, 2004, ADDICT BEHAV, V29, P1095, DOI 10.1016/j.addbeh.2004.03.022
  25. Sanchez ZM, 2011, J ADOLESCENT RES, V26, P591, DOI 10.1177/0743558411402337
  26. Sanchez ZVDM, 2008, SUBST USE MISUSE, V43, P1476, DOI 10.1080/10826080802183288
  27. Silva LVER, 2006, REV SAUDE PUBL, V40, P280, DOI 10.1590/S0034-89102006000200014
  28. Steinman KJ, 2008, HEALTH EDUC BEHAV, V35, P22, DOI 10.1177/1090198105284839
  29. Stempliuk VD, 2005, REV BRAS PSIQUIATR, V27, P185, DOI 10.1590/S1516-44462005000300006
  30. Strote J, 2002, J ADOLESCENT HEALTH, V30, P64, DOI 10.1016/S1054-139X(01)00315-9
  31. Tavares BF, 2001, REV SAUDE PUBL, V35, P150, DOI 10.1590/S0034-89102001000200008
  32. Terry-McElrath YM, 2011, ADDICT BEHAV, V36, P116, DOI 10.1016/j.addbeh.2010.09.005
  33. Turner-Musa J, 2007, AM J HEALTH BEHAV, V31, P495
  34. UNODC, 2008, WORLD DRUG REP 2008
  35. Walker C, 2007, PSYCHOL ADDICT BEHAV, V21, P84, DOI 10.1037/0893-164X.21.1.84
  36. Wallace John M Jr, 2007, Soc Work Public Health, V23, P193, DOI 10.1080/19371910802152059
  37. WHO, 2011, GLOB STAT REP ALC HL
  38. World Health organization, 2004, GLOB STAT REP ALC
  39. Yeung JWK, 2009, PSYCHOL REP, V105, P255, DOI 10.2466/PR0.105.1.255-266

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/40